Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

NCT00172380 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Taiwan University Hospital